Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Bower

Showing results (11-20 of 252) with videos related to

Pageof 26
Sort By:
The Lancet. Oncology|July 22, 2014
Exploiting interleukin 6 in multicentric Castleman's diseaseMark Bower, Justin Stebbing
Cancer Chemotherapy and Biological Response Modifiers|August 23, 2005
AIDS-associated malignanciesMark Bower, Justin Stebbing
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2004
HIV and the risk of lung cancerThomas Powles, Mark Bower
The Journal of Infectious Diseases|February 24, 2012
Cell-free DNA as a biomarker in the context of cancer, viruses, and methylationJustin Stebbing, Mark Bower
The Lancet. HIV|September 30, 2022
Lung cancer in people living with HIVAdam P Januszewski, Mark Bower
F1000 Medicine Reports|February 2, 2011
HIV-associated anal cancerThomas Newsom-Davis, Mark Bower
Clinical Advances in Hematology & Oncology : H&O|March 10, 2012
What Is the best treatment for HIV-associated multicentric Castleman disease?Mark Bower, Alessia Dalla Pria
AIDS (London, England)|August 2, 2013
Will local ablation of high grade anal intraepithelial neoplasia prevent invasive anal cancer?Alessia Dalla Pria, Mark Bower
Current Opinion in Infectious Diseases|December 10, 2014
Facing up to the ongoing challenge of Kaposi's sarcomaRebecca C Robey, Mark Bower
Current Opinion in Oncology|June 26, 2012
Impact of highly effective antiretroviral therapy on the risk for Hodgkin lymphoma among people with human immunodeficiency virus infectionJames J Goedert, Mark Bower
Pageof 26

Showing results (11-20 of 252) with videos related to

Sort By:
Pageof 26
The Lancet. Oncology|July 22, 2014
Exploiting interleukin 6 in multicentric Castleman's diseaseMark Bower, Justin Stebbing
Cancer Chemotherapy and Biological Response Modifiers|August 23, 2005
AIDS-associated malignanciesMark Bower, Justin Stebbing
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2004
HIV and the risk of lung cancerThomas Powles, Mark Bower
The Journal of Infectious Diseases|February 24, 2012
Cell-free DNA as a biomarker in the context of cancer, viruses, and methylationJustin Stebbing, Mark Bower
The Lancet. HIV|September 30, 2022
Lung cancer in people living with HIVAdam P Januszewski, Mark Bower
F1000 Medicine Reports|February 2, 2011
HIV-associated anal cancerThomas Newsom-Davis, Mark Bower
Clinical Advances in Hematology & Oncology : H&O|March 10, 2012
What Is the best treatment for HIV-associated multicentric Castleman disease?Mark Bower, Alessia Dalla Pria
AIDS (London, England)|August 2, 2013
Will local ablation of high grade anal intraepithelial neoplasia prevent invasive anal cancer?Alessia Dalla Pria, Mark Bower
Current Opinion in Infectious Diseases|December 10, 2014
Facing up to the ongoing challenge of Kaposi's sarcomaRebecca C Robey, Mark Bower
Current Opinion in Oncology|June 26, 2012
Impact of highly effective antiretroviral therapy on the risk for Hodgkin lymphoma among people with human immunodeficiency virus infectionJames J Goedert, Mark Bower
Pageof 26